You can buy or sell Affimed and other stocks, options, ETFs, and crypto commission-free!
Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. Read More The company was founded in 2000 and is headquartered in Heidelberg, Germany.
Heidelberg, Baden Wuerttemberg
52 Week High
52 Week Low
Yahoo FinanceMay 22
Affimed N.V. Q1 2019 Earnings Call Transcript
Logo of jester cap with thought bubble. Image source: The Motley Fool. Affimed N.V. (NASDAQ: AFMD) Q1 2019 Earnings Call May 22, 2019, 8:30 a.m. ET Scroll to continue with content Ad Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day and welcome to Affimed First Quarter 2019 Financial Results and Corporate Update Conference Call. At this time all participants are in a listen-only mode. As a reminder, today's conference is being recorded. I'll ...
Seeking AlphaMay 22
Affimed bails on AFM11; shares down 9% premarket
Affimed N.V. (NASDAQ:AFMD) plans to focus its R&D investments on advancing clinical trials for innate cell engager candidates, AFM13 and AFM24 and also provides corporate updates.
-$0.17 per share
$0.03 per share